VYZULTA ฮŸphthalmic solution Ref.[10112] Active ingredients: Latanoprostene bunod

Source: FDA, National Drug Code (US)  Revision Year: 2019 

Product description

VYZULTA (latanoprostene bunod ophthalmic solution), 0.024% is a prostaglandin analog formulated as a sterile topical ophthalmic solution. VYZULTA contains the active ingredient latanoprostene bunod 0.24 mg/mL, the preservative benzalkonium chloride 0.2 mg/mL, and the following inactive ingredients: polysorbate 80, glycerin, EDTA, and water. The formulation is buffered to pH 5.5 with citric acid/sodium citrate.

Its chemical name is 4-(Nitrooxy)butyl (5Z)7{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate. Its molecular formula is C27H41NO8. Molecular weight: 507.62.

Its chemical structure is:

Latanoprostene bunod is a colorless to yellow oil.

Dosage Forms and Strengths

VYZULTA is a topical ophthalmic solution containing latanoprostene bunod, 0.24 mg/mL.
How Supplied

VYZULTA (latanoprostene bunod ophthalmic solution), 0.024% is supplied in low density polyethylene bottles with dropper tips and turquoise caps in the following sizes:

  • 2.5 mL fill in a 4 mL white container – NDC 24208-504-02
  • 5 mL fill in a 7.5 mL natural container – NDC 24208-504-05

Drugs

Drug Countries
VYZULTA Brazil, Canada, Hong Kong, Turkey, United States
 
Next: Usage >

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈